Serious riskFDA DeviceClass I

Arrow arterial catheter kits recalled for possible sterility loss

Arrow International recalled multiple arterial catheter kits because they contain lidocaine, bupivacaine, and saline solution from a supplier with quality control issues. If the sterilization of these injectable products was compromised, patients could face serious or life-threatening infections.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have one of the affected kits, do not use it.
  2. Contact your facility's pharmacy or medical device manager immediately with the product lot number.
  3. Follow your institution's procedures for handling recalled medical devices.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Description/REF: RA CATH KIT: 20 GA X 1-1/2IN/NA-04220-1A; RA CATH KIT: 20 GA X 1-1/2IN/NA-04220-X1A; ARTERIAL CATHETER KIT: 18 GA X 16 CM/ASK-04018-HCA; ARTERIAL CATHETER KIT: 18 GA X 16 CM/ASK-04018-UPM; RA CATH KIT: 20 GA X 1-3/4IN/ASK-04020-HC; ARTERIAL LINE KIT: 20 GA X 5IN (12 CM)/ASK-04020-HMC; RADIAL ARTERY CATHETER KIT: 20 GA X 30MM/ASK-04020-MMC; RA CATH KIT: 20 GA X 1-1/2IN (3.81 CM)/ASK-04020-SV; ARTERIAL CATH KIT: 20 GA X 5 IN (12 CM)/ASK-04100-AMC-S1; ARTERIAL CATHETER KIT: 20 GA X 12 CM/ASK-04100-NS; RADIAL ARTERY KIT/ASK-04500-AH; RAD ART:20GAX3.81CM / ART LINE:20GAX12CM/ASK-04500-HF-S; ARTERIAL LINE KIT: 1L 20 GA X 12 CM/ASK-04510-HA; ARTERIAL LINE KIT: 20 GA. X 5 IN (12 CM)/ASK-04510-HF; ARTERIAL LINE KIT: 20 GA X 5 IN (12 CM)/ASK-04510-IHC1; ARTERIAL LINE KIT: 20 GA X 5 IN (12 CM)/ASK-04510-MSK2; ARTERIAL CATH KIT: 20GA X 5IN/ASK-04510-NS; ARTERIAL CATHETER KIT: 20 GA X 12 CM/FS-04510-S; ARTERIAL LINE KIT/HF-04510-1; RA CATH KIT: 20 GA X 1-3/4IN/ASK-04020-BSM; RA CATH KIT: 20 GA X 1 3/4 IN (4.45CM)/ASK-04020-HH1; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-JMH1; RA CATH KIT: 20 GA X 1-3/4 IN/ASK-04020-MAS; RA CATH KIT: 20 GA X 1 3/4 IN/ASK-04020-MCC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MHT; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MI; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-MIHS; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MUSC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-NCB; RA CATH KIT: 20 GA X 1 3/4 IN/ASK-04020-PMC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-SPH; RA CATH SET: 20 GA X 1-3/4IN (4.45CM)/ASK-04020-UPM; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-UR1; RA CATH KIT: 20 GA X 4.45 CM/NA-04020-X1A; RA CATH KIT: 20 GA X 1-3/4IN/WBH-04020-1; CVC KIT: 20 GA X 12CM/ASK-04510-UCLA; ARTERIAL ACCESS TRAY WITH .025IN SWG/ASK-04001-BW1
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 35 products — see all of them.

Details

Units affected
310,606
Illnesses reported
None reported
Manufactured in
3015 Carrington Mill Blvd, Morrisville, NC, United States
Classification
Class I
Recall number
Z-2397-2026

In the FDA's words

Description
Description/REF: RA CATH KIT: 20 GA X 1-1/2IN/NA-04220-1A; RA CATH KIT: 20 GA X 1-1/2IN/NA-04220-X1A; ARTERIAL CATHETER KIT: 18 GA X 16 CM/ASK-04018-HCA; ARTERIAL CATHETER KIT: 18 GA X 16 CM/ASK-04018-UPM; RA CATH KIT: 20 GA X 1-3/4IN/ASK-04020-HC; ARTERIAL LINE KIT: 20 GA X 5IN (12 CM)/ASK-04020-HMC; RADIAL ARTERY CATHETER KIT: 20 GA X 30MM/ASK-04020-MMC; RA CATH KIT: 20 GA X 1-1/2IN (3.81 CM)/ASK-04020-SV; ARTERIAL CATH KIT: 20 GA X 5 IN (12 CM)/ASK-04100-AMC-S1; ARTERIAL CATHETER KIT: 20 GA X 12 CM/ASK-04100-NS; RADIAL ARTERY KIT/ASK-04500-AH; RAD ART:20GAX3.81CM / ART LINE:20GAX12CM/ASK-04500-HF-S; ARTERIAL LINE KIT: 1L 20 GA X 12 CM/ASK-04510-HA; ARTERIAL LINE KIT: 20 GA. X 5 IN (12 CM)/ASK-04510-HF; ARTERIAL LINE KIT: 20 GA X 5 IN (12 CM)/ASK-04510-IHC1; ARTERIAL LINE KIT: 20 GA X 5 IN (12 CM)/ASK-04510-MSK2; ARTERIAL CATH KIT: 20GA X 5IN/ASK-04510-NS; ARTERIAL CATHETER KIT: 20 GA X 12 CM/FS-04510-S; ARTERIAL LINE KIT/HF-04510-1; RA CATH KIT: 20 GA X 1-3/4IN/ASK-04020-BSM; RA CATH KIT: 20 GA X 1 3/4 IN (4.45CM)/ASK-04020-HH1; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-JMH1; RA CATH KIT: 20 GA X 1-3/4 IN/ASK-04020-MAS; RA CATH KIT: 20 GA X 1 3/4 IN/ASK-04020-MCC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MHT; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MI; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-MIHS; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-MUSC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-NCB; RA CATH KIT: 20 GA X 1 3/4 IN/ASK-04020-PMC; RA CATH KIT: 20 GA X 1-3/4IN (4.45 CM)/ASK-04020-SPH; RA CATH SET: 20 GA X 1-3/4IN (4.45CM)/ASK-04020-UPM; RA CATH KIT: 20 GA X 1 3/4 IN (4.45 CM)/ASK-04020-UR1; RA CATH KIT: 20 GA X 4.45 CM/NA-04020-X1A; RA CATH KIT: 20 GA X 1-3/4IN/WBH-04020-1; CVC KIT: 20 GA X 12CM/ASK-04510-UCLA; ARTERIAL ACCESS TRAY WITH .025IN SWG/ASK-04001-BW1 Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries. REF(Material)/UDI-DI/Lot(Batch): NA-04220-1A/10801902193275/33F26B0027; NA-04220-X1A/10801902193275/33F24G0553, 33F25E0272, 33F25E1053, 33F25H0760, 33F25J0636; ASK-04018-HCA/10801902119268/33F24A0078; ASK-04018-UPM/50801902117644, 10801902193275/33F23B0953, 33F24A0389, 33F24B0140, 33F24D0028, 33F24H0480, 33F24J0550, 33F24K0164, 33F25A0505, 33F25C0742, 33F25C0792, 33F25E0961, 33F25E1070, 33F25E1071, 33F25E1072, 33F25G0105, 33F25H0062, 33F25J0866, 33F25L0353, 33F26B0507; ASK-04020-HC/10801902121384, 10801902193275/33F24A0828, 33F24B0246, 33F24C0148, 33F24D0113, 33F24G0409, 33F24J0559, 33F24K0172, 33F24L0693, 33F25C0136, 33F25C0933, 33F25E0128, 33F25H0070, 33F25L0356; ASK-04020-HMC/10801902117691, 10801902193275/33F24A0324, 33F24A0743, 33F24B0248, 33F24C0150, 33F24D0115, 33F24H0475, 33F24K0174, 33F24L0802, 33F25H0072, 33F25J0872, 33F25L0395, 33F26B0650, 33S24A0743, 33S24C0150, 33F26B0673; ASK-04020-MMC/10801902117769, 10801902193275/33F24C0160, 33F24D0123, 33F24E0423, 33F24G0420, 33F24H0487, 33F24J0571, 33F24K0183, 33F24L0692, 33F25A0523, 33F25C0974, 33F25E0139, 33F25H0081, 33F25J0880, 33F25L0346, 33F25M0853; ASK-04020-SV/10801902117837, 10801902117837/33F24A0868, 33F24B0269, 33F24E0436, 33F24E0437, 33F24L0746, 33F25H0087, 33F25J0885, 33F26B0512; ASK-04100-AMC-S1/10801902124927, 10801902193275/33F24D0139, 33F24E0446, 33F24G0439, 33F24K0199, 33F25A0532, 33F25E0153, 33F25G0116, 33F25H0093, 33F25J0516, 33F26B0656; ASK-04100-NS/10801902193275, 10801902117929/33F24G0440, 33F24L0579, 33F24M0266, 33F25A0533, 33F25C0151, 33F25C0788, 33F25E0155, 33F25H0095, 33F25J0518, 33F25K0256, 33F25L0448, 33F25M0945, 33F26B0649, 33F26B0667; ASK-04500-AH/10801902114041, 10801902193275/33F24A0153, 33F24A0803, 33F24B0282, 33F24C0181, 33F24E0452, 33F24G0444, 33F24J0586, 33F25A0538, 33F25H0101, 33F25J0893; ASK-04500-HF-S/10801902118001, 10801902193275/33F24A0141, 33F24A0753, 33F24A1157, 33F24B0283, 33F24C0182, 33F24D0143, 33F24E0453, 33F24G0445, 33F24J0587, 33F24K0206, 33F24L0766, 33F25C0154, 33F25C0966, 33F25E0161, 33F25H0102, 33F25J0894, 33F25L0492, 33R25C0966; ASK-04510-HA/10801902193275/33F24J0591, 33F24K0210, 33F25B0685, 33F25C0911, 33F25E0166, 33F25E0993, 33F25J0524, 33F25L0449; ASK-04510-HF/10801902193275, 10801902118025/33F24G0450, 33F24J0305, 33F24K0211, 33F24L0543, 33F24L0558, 33F25A0540, 33F25C0896, 33F25E0167, 33F25G0119, 33F25H0104, 33F25J0525, 33F25K0412, 33F25L0339, 33F26B0648, 33F26B0666, 33F26C0588; ASK-04510-IHC1/10801902193275/33F24J0306, 33F24L0699, 33F25C0157, 33F25C0782, 33F25E0168, 33F25H0105, 33F25L0475; ASK-04510-MSK2/10801902118049, 10801902193275/33F24A0872, 33F24B0290, 33F24D0150, 33F24E0461, 33F24G0453, 33F24J0594, 33F25A0541, 33F25C0852, 33F25E0170, 33F25H0740; ASK-04510-NS/10801902193275, 10801902224177/33F25K0324, 33F26B0653; FS-04510-S/10801902193
Hazard
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

35 products in this recall

Arrow kits with lidocaine and bupivacaine recalled for sterility risk

Arrow is recalling 35 kits and sets that contain lidocaine, bupivacaine, or 0.9% sodium chloride from a supplier that was itself recalled for quality issues. If the sterility of these water-based injectable drugs is compromised, it could lead to serious or life-threatening injuries. No injuries have been reported, and the products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherSterilityMedical devicesSold nationwideMore from FDA Device